Recurrent Nasopharynx Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB09037 | Pembrolizumab | 1 / 2 | Completed | 1 |
DB02546 | Vorinostat | 1 / 2 | Completed | 1 |
DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Active Not Recruiting | 1 |
DB11886 | Infigratinib | 2 | Terminated | 1 |
DB09035 | Nivolumab | 2 | Completed | 1 |
DB00958 | Carboplatin | 3 | Terminated | 1 |
DB00773 | Etoposide | 3 | Terminated | 1 |
DB01181 | Ifosfamide | 3 | Terminated | 1 |